medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2022, Number 1

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2022; 38 (1)

Sickle cell disease and family planning

Agramonte LOM, Goodridge SM, Sidiki TA

Language: Spanish
References: 37
Page: 1-16
PDF size: 324.03 Kb.


ABSTRACT

Introduction: Family planning in pregnant women with sickle cell disease contributes to reducing the number of pregnancies and maternal-fetal morbidity and mortality.
Objective: To analyze family planning concepts applicable to pregnant women with sickle cell disease and propose counseling actions aimed at reducing the indicators of maternal fetal morbidity and mortality related to this disease.
Methods: A literature review was carried out, in English and Spanish, through the Pubmed website and the academic Google search engine of articles published in the last 5 years, with analysis and summary of the reviewed bibliography.
Analysis and synthesis of information: The vast majority of patients with sickle cell disease are unaware of the concepts of sexual and reproductive health as well as FP, so many become women with multiple pregnancies that end in abortions, with a high risk of complications severe and 2.5 times more likely to die during pregnancy and the puerperium than a non-ill pregnant woman. The application of a group of measures aimed at making these concepts known from the hematology consultation, brings these patients and their partner closer to making the correct decision about when and how many children to have.
Conclusion: Family planning as a medical care process in sickle cell disease, with direct participation of the hematologist, as primary care physician throughout the life of these pregnant women, contributes to strengthening the relationship between the work of the healthcare team, the couple and decreases morbidity and fetal maternal mortality.


REFERENCES

  1. OPS/OMS. Plan Estratégico de transversalización. Perspectiva de Género en Salud 2014-2018 en el marco del Plan de Salud de Centroamérica y República Dominicana. 2014. [acceso: 25/04/2021]; Disponible en: http://www.cide.edu/docs/buenas-practicas/equidad-genero/PPSalud.pdf

  2. Martínez Boloña Y, Díaz Bernal Z. Programa de Planificación Familiar y Riesgo Reproductivo sensible al género. RCMGI. 2015 [acceso: 25/03/20211];31(4): Disponible en: http://www.revmgi.sld.cu/index.php/mgi/article/view/83

  3. Fondo de Población de las Naciones Unidas (UNFPA). Estado de la población mundial 2019. Un asunto pendiente la defensa de los derechos y la libertad de decidir de todas las personas. 2019. Nov 1; pp176. ISBN: 9780897140416. [acceso: 25/04/2021]; Disponible en: https://www.unfpa.org/es

  4. Carmine L. Contraception for Adolescents with Medically Complex Conditions. Curr Probl Pediatr Adolesc Health Care. 2018 Dec;48(12):345-57. DOI: https://10.1016/j.cppeds.2018.11.004

  5. Stover J, Winfrey W. The effects of family planning and other factors on fertility, abortion, miscarriage, and stillbirths in the Spectrum model. BMC Public Health. 2017 Nov 7;17(Suppl 4):775. DOI: https://10.1186/s12889-017-4740-7

  6. Rahmani AM, Wade B, Riley W. Evaluating the impact a proposed family planning model would have on maternal and infant mortality in Afghanistan. Int J Health Plann Manage. 2015 Jan-Mar;30(1):71-85. DOI: https://10.1002/hpm.2206

  7. Ackerson K, Zielinski R.Factors influencing use of family planning in women living in crisis affected areas of Sub-Saharan Africa: A review of the literature. Midwifery. 2017 Nov; 54:35-60. DOI: https://10.1016/j.midw.2017.07.021

  8. Fagan T, Dutta A, Rosen J, Olivetti A, Klein K. Family Planning in the Context of Latin America's Universal Health Coverage Agenda. Glob Health Sci Pract. 2017 Sep 28;5(3):382-98. DOI: https://10.9745/GHSP-D-17-00057

  9. Gaffikin L, Engelman R. Family planning as a contributor to environmental sustainability: weighing the evidence. Curr Opin Obstet Gynecol. 2018 Dec; 30(6):425-31. DOI: https://10.1097/GCO.0000000000000489

  10. Kjellander C, Sennström MK, Stiller V, Ågren A. Sickle cell anemia causes varied symptoms and high morbidity. Serious prognosis in the most common genetic disease in the world. Lakartidningen. 2015 Mar 3;112. pii: DCPM. Swedish.

  11. Phillips C, Boyd MP. Perinatal and Neonatal Implications of Sickle Cell Disease. Nurs Womens Health. 2017 Dec;21(6):474-487. DOI: https://10.1016/j.nwh.2017.10.007

  12. Oteng-Ntim E, Meeks D, Seed PT, Webster L, Howard J, Doyle P et al. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis. Blood. 2015 May;125(21):3316-25. DOI: https://10.1182/blood-2014-11-607317

  13. Haturvedi S, DeBaun MR. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years. Am J Hematol. 2016 Jan;91(1):5-14. DOI: https://10.1002/ajh.24235

  14. Sundd P, Gladwin MT, Novelli EM. Pathophysiology of Sickle Cell Disease. Annu Rev Pathol. 2019 Jan;14:263-292 DOI: https://10.1146/annurev-pathmechdis-012418-012838

  15. Oteng-Ntim E. Pregnancy in women with sickle cell disease is associated with risk of maternal and perinatal mortality and severe morbidity. Evid Based Nurs. 2017 Apr;20(2):43. DOI: https://10.1136/eb-2016-102450

  16. Rizk S, Pulte ED, Axelrod D, Ballas SK.Perinatal Maternal Mortality in Sickle Cell Anemia: Two Case Reports and Review of the Literature. Hemoglobin. 2017 Jul - Nov; 41(4-6):225-9. DOI: https://10.1080/03630269.2017.1397017

  17. Lari NF, DeBaun MR, Oppong SA.The emerging challenge of optimal blood pressure management and hypertensive syndromes in pregnant women with sickle cell disease: a review. Expert Rev Hematol. 2017 Nov;10(11):987-94. DOI: https://10.1080/17474086.2017.1379895

  18. Noubouossie D, Key NS.Sickle cell disease and venous thromboembolism in pregnancy and the puerperium. Thromb Res. 2015 Feb;135 Suppl 1:S46-8. DOI: https://10.1016/S0049-3848(15)50442-8

  19. Cardenes N, Corey C, Geary L, Jain S, Zharikov S, Barge S, et al. Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activation. Blood. 2014 May; 123(18):2864-72. DOI: https://10.1182/blood-2013-09-529420

  20. Bennewitz MF, Jimenez MA, Vats R, Tutuncuoglu E, Jonassaint J, Kato GJ, et al. Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli. JCI Insight. 2017 Jan 12;2(1):e89761. DOI: https://10.1172/jci.insight.89761

  21. Guarda CCD, Santiago RP, Fiuza LM, Aleluia MM, Ferreira JRD, Figueiredo CVB, et al Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia. Expert Rev Hematol. 2017 Jun; 10(6):533-541. DOI: https://10.1080/17474086.2017.1327809

  22. Noubouossie D, Key NS, Ataga KI Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies. Blood Rev. 2016 Jul;30(4):245-56. DOI: https://10.1016/j.blre.2015.12.003

  23. Grossman KB, Arya R, Peixoto AB, Akolekar R, Staboulidou I, Nicolaides KH. Maternal and pregnancy characteristics affect plasma fibrin monomer complexes and D-dimer reference ranges for venous thromboembolism in pregnancy. Am J Obstet Gynecol. 2016 Oct;215(4):466.e1-8 DOI: https://10.1016/j.ajog.2016.05.013

  24. Dallmann A, Ince I, Meyer M, Willmann S, Eissing T, Hempel G. Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy. Clin Pharmacokinet. 2017 Nov;56(11):1303-1330. DOI: https://10.1007/s40262-017-0539-z

  25. van Tuijn CFJ, Schimmel M, van Beers EJ, Nur E, Biemond BJ. Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up study. Am J Hematol. 2017 Oct;92(10):E584-E590. DOI: https://10.1002/ajh.24855

  26. Bersamin M, Fisher DA, Marcell AV, Finan LJ.Deficits in young men's knowledge about accessing sexual and reproductive health services. J Am Coll Health. 2017 Nov-Dec;65(8):579-584. DOI: https://10.1080/07448481.2017.1352589

  27. Rodríguez Morales Vilma, Díaz Bernal Z, Castañeda Abascal I, Rodríguez Cabrera A. Conocimientos y actitudes de varones acerca de la planificación familiar. Rev Cubana Salud Pública [Internet].2016 Mar [acceso: 25/04/2021];42(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662016000100011&lng=es.

  28. González Labrador I, Miyar Pieiga E. Consideraciones sobre planificación familiar: métodos anticonceptivos. Rev Cubana Med Gen Integr [Internet]. 2001 Ago [acceso: 25/04/2021];17(4): 367-78. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252001000400010&lng=es.

  29. Rigol Ricardo O, Santisteban Alba S. Obstetricia y Ginecología. 3ra ed. La Habana: Ciencias Médicas; 2014. Disponible en: http://www.bvs.sld.cu/libros_texto/ginecologia_obstetricia_3raedicion/cap25.pdf

  30. San Gil Suárez CI, Villazán Martín C, Ortega San Gil Y. Caracterización de la anemia durante el embarazo y algunos factores de riesgo asociados, en gestantes del municipio regla. Rev Cubana Med Gen Integr. 2014 Mar [acceso: 25/03/2021];30(1):71-81. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252014000100007&lng=es

  31. Koura GK, Ouedraogo S, Le Port A, Watier L, Cottrell G, Guerra J, et al. Anaemia during pregnancy: impact on birth outcome and infant haemoglobin level during the first 18 months of life. Trop Med Int Health. 2012 Mar;17(3):283-91. DOI: https://10.1111/j.1365-3156.2011.02932.x

  32. Desai G, Anand A, Shah P, Shah S, Dave K, Bhatt H .Sickle cell disease and pregnancy outcomes: a study of the community-based hospital in a tribal block of Gujarat, India. J Health Popul Nutr. 2017 Jan;36(1):3. DOI: https://10.1186/s41043-017-0079-z

  33. Costa VM, Viana MB, Aguiar RA. Pregnancy in patients with sickle cell disease: maternal and perinatal outcomes. J Matern Fetal Neonatal Med. 2015 Apr;28(6):685-9. DOI: https://10.3109/14767058.2014.928855

  34. Sarduy-Rodríguez M, Rodríguez-Martínez A, Sánchez-Ramírez N. Sepsis en pacientes con rotura prematura de membranas pretérmino. Rev Cubana Obstet Ginecol. 2016 [acceso 23/02/2021];42(3): Disponible en: http://revginecobstetricia.sld.cu/index.php/gin/article/view/76

  35. Elenga N, Adeline A, Balcaen J, Vaz T, Calvez M, Terraz A. Pregnancy in Sickle Cell Disease Is a Very High-Risk Situation: An Observational Study. Obstet Gynecol Int. 2016; 2016:9069054. DOI: https://10.1155/2016/9069054

  36. Silva FAC, Ferreira ALCG, Hazin-Costa MF, Dias MLG, Araújo AS, Souza AI, Adverse clinical and obstetric outcomes among pregnant women with different sickle cell disease genotypes. Int J Gynaecol Obstet. 2018 Oct;143(1):89-93. DOI: https://10.1002/ijgo.12626

  37. Burgos Luna JM, Páez Rúa DM, Ruiz Ordoñez I, Fernández PA, Escobar Vidarte MF. Description of criteria for near miss in high-complexity obstetric population with sickle cell anemia: an observational study. J Matern Fetal Neonatal Med. 2018 Jan;31(1):1-6. DOI: https://10.1080/14767058.2016.1176137




2020     |     www.medigraphic.com